Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Onkologie
|
June 1, 1990
Etoposide, adriamycin, and cisplatinum (EAP) combination chemotherapy for advanced gastric cancer. A phase II trial by the "Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)"
U Räth, H Flechtner, J Selbach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 1999
Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group
H Flechtner, J U Rüffer, M Henry-Amar, et al.
Onkologie
|
April 1, 1987
5-Fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) combination chemotherapy for advanced gastric carcinoma. A phase-II trial by the "chemotherapiegruppe gastrointestinaler tumoren (CGT)"
H Flechtner, W Queisser, M E Heim, et al.
Annals of Hematology
|
August 12, 2003
Recombinant human erythropoietin, epoetin beta, in patients with relapsed lymphoma treated with aggressive sequential salvage chemotherapy--results of a randomized trial
J-P Glossmann, A Engert, G Wassmer, et al.
Journal of the National Cancer Institute
|
March 3, 1993
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology
N K Aaronson, S Ahmedzai, B Bergman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 29, 2000
Quality of life evaluation in oncological clinical trials - the EORTC model. The EORTC Quality of Life Study Group
J de Haes, D Curran, T Young, et al.
Restorative Neurology and Neuroscience
|
November 28, 2002
Quality of life in children with traumatic brain injury--basic issues, assessment, and recommendations
Ulrike Ravens-Sieberer, Peter D Patrick, B Benz, et al.
British Journal of Cancer
|
January 17, 2013
Sexual quality of life in Hodgkin Lymphoma: a longitudinal analysis by the German Hodgkin Study Group
K Behringer, H Müller, H Görgen, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
August 9, 2020
Minimally important differences for interpreting the EORTC QLQ-C30 in patients with advanced colorectal cancer treated with chemotherapy
J Z Musoro, S C Sodergren, C Coens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 2012
Effect of completion-time windows in the analysis of health-related quality of life outcomes in cancer patients
D E Ediebah, C Coens, J T Maringwa, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Onkologie
|
June 1, 1990
Etoposide, adriamycin, and cisplatinum (EAP) combination chemotherapy for advanced gastric cancer. A phase II trial by the "Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)"
U Räth, H Flechtner, J Selbach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 1999
Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group
H Flechtner, J U Rüffer, M Henry-Amar, et al.
Onkologie
|
April 1, 1987
5-Fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) combination chemotherapy for advanced gastric carcinoma. A phase-II trial by the "chemotherapiegruppe gastrointestinaler tumoren (CGT)"
H Flechtner, W Queisser, M E Heim, et al.
Annals of Hematology
|
August 12, 2003
Recombinant human erythropoietin, epoetin beta, in patients with relapsed lymphoma treated with aggressive sequential salvage chemotherapy--results of a randomized trial
J-P Glossmann, A Engert, G Wassmer, et al.
Journal of the National Cancer Institute
|
March 3, 1993
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology
N K Aaronson, S Ahmedzai, B Bergman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 29, 2000
Quality of life evaluation in oncological clinical trials - the EORTC model. The EORTC Quality of Life Study Group
J de Haes, D Curran, T Young, et al.
Restorative Neurology and Neuroscience
|
November 28, 2002
Quality of life in children with traumatic brain injury--basic issues, assessment, and recommendations
Ulrike Ravens-Sieberer, Peter D Patrick, B Benz, et al.
British Journal of Cancer
|
January 17, 2013
Sexual quality of life in Hodgkin Lymphoma: a longitudinal analysis by the German Hodgkin Study Group
K Behringer, H Müller, H Görgen, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
August 9, 2020
Minimally important differences for interpreting the EORTC QLQ-C30 in patients with advanced colorectal cancer treated with chemotherapy
J Z Musoro, S C Sodergren, C Coens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 2012
Effect of completion-time windows in the analysis of health-related quality of life outcomes in cancer patients
D E Ediebah, C Coens, J T Maringwa, et al.
Page
of 4